The prices of similar cardiac implants in the U.S. were higher than in the four largest E.U. markets between 2006 and 2014, according to a new study by British researchers. U.S. prices were two to six times higher than those in Germany and varied widely among the European countries studied.
The study, published in the journal Health Affairs, examined the prices charged by large hospitals in six U.S. markets and in France, Germany, Italy and the U.K. for coronary stents, pacemakers and implantable cardioverter defibrillators (ICDs). It is the first systematic comparison of cardiac implant prices between the U.S. and the largest European markets over time, according to the researchers from the London School of Economics and Political Science.